Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Roivant Sciences (ROIV) Return on Equity: 2021-2025

Historic Return on Equity for Roivant Sciences (ROIV) over the last 4 years, with Sep 2025 value amounting to -0.03%.

  • Roivant Sciences' Return on Equity fell 2.00% to -0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.03%, marking a year-over-year decrease of 2.00%. This contributed to the annual value of 0.07% for FY2025, which is 12.00% up from last year.
  • Per Roivant Sciences' latest filing, its Return on Equity stood at -0.03% for Q3 2025, which was down 263.64% from 0.02% recorded in Q2 2025.
  • In the past 5 years, Roivant Sciences' Return on Equity ranged from a high of 0.06% in Q4 2024 and a low of -0.94% during Q2 2023.
  • For the 3-year period, Roivant Sciences' Return on Equity averaged around -0.25%, with its median value being -0.05% (2024).
  • In the last 5 years, Roivant Sciences' Return on Equity tumbled by 54bps in 2022 and then skyrocketed by 88bps in 2024.
  • Over the past 5 years, Roivant Sciences' Return on Equity (Quarterly) stood at -0.39% in 2021, then crashed by 54bps to -0.93% in 2022, then soared by 71bps to -0.22% in 2023, then grew by 27bps to 0.06% in 2024, then dropped by 2bps to -0.03% in 2025.
  • Its Return on Equity was -0.03% in Q3 2025, compared to 0.02% in Q2 2025 and 0.06% in Q4 2024.